Department of Gastroenterology, Academic Medical Center, Amsterdam, Netherlands.
Endoscopy. 2012 Dec;44(12):1096-104. doi: 10.1055/s-0032-1325731. Epub 2012 Oct 29.
Endoscopic resection with radiofrequency ablation (RFA) 6 weeks later safely and effectively eradicates Barrett's esophagus with high grade dysplasia (HGD) and early cancer. After widespread endoscopic resection, related scarring may hamper balloon-based circumferential RFA (c-RFA). However c-RFA immediately followed by endoscopic resection in the same session might avoid the impact of scarring and reduce laceration and stenosis risk. We aimed to assess the feasibility of such an approach.
Patients with Barrett's esophagus ≥ 3 cm and ≥ 1 visible lesion (HGD/early cancer) were included. Visible lesions were marked with cautery, and c-RFA (12 J/cm2) was delivered using two applications and a cleaning step, followed by resection of the delineated area. Outcome measures were surface regression of Barrett's esophagus at 3 months, need for subsequent c-RFA, complications, and quality of resection specimens.
24 patients (20 men, 4 women; mean age 68 years, standard deviation [SD] 12; Barrett's esophagus median length C6M8) underwent single-session c-RFA + endoscopic resection, providing a median of 4 (interquartile range [IQR] 2 - 6) resection specimens (early cancer 18 patients; HGD 6). Complications included 1 perforation, 4 bleedings, and 5 stenoses; all were managed endoscopically. Specimens allowed assessment of neoplasia depth, differentiation, and lymphatic/vascular invasion. Median Barrett's esophagus surface regression at 3 months was 95 %. No patient required a second c-RFA procedure and 40 % required repeat endoscopic resection for visible lesions. Complete response for neoplasia was achieved in 100 % and complete response for intestinal metaplasia (CR-IM) in 95 %.
c-RFA followed by endoscopic resection in the same session is feasible, but technically demanding and associated with a substantial rate of complications and repeat endoscopic resection. This approach should be reserved for selected cases in expert centers, with endoscopic resection and RFA 6 - 8 weeks later remaining the standard combined approach.
内镜下射频消融(RFA)联合 6 周后切除术安全有效地根除伴有高级别异型增生(HGD)和早期癌症的 Barrett 食管。广泛内镜下切除后,相关的瘢痕可能会妨碍基于球囊的环形 RFA(c-RFA)。然而,在同一次治疗中,c-RFA 后立即进行内镜下切除可能会避免瘢痕的影响,并降低撕裂和狭窄的风险。我们旨在评估这种方法的可行性。
纳入 Barrett 食管长度≥3cm 且有≥1个可见病灶(HGD/早期癌症)的患者。用烧灼标记可见病灶,使用两个应用程序和一个清洁步骤进行 c-RFA(12J/cm2),然后切除划定区域。主要转归指标是 3 个月时 Barrett 食管表面消退情况、是否需要后续 c-RFA、并发症和切除标本质量。
24 例患者(20 名男性,4 名女性;平均年龄 68 岁,标准差[SD] 12;Barrett 食管长度中位数 C6M8)接受了单次 c-RFA+内镜下切除术,提供了中位数为 4(四分位距[IQR] 2-6)个切除标本(18 例患者为早期癌症;6 例为 HGD)。并发症包括 1 例穿孔、4 例出血和 5 例狭窄;所有并发症均经内镜处理。标本可评估肿瘤深度、分化程度以及淋巴管/血管侵犯情况。3 个月时 Barrett 食管表面消退的中位数为 95%。无患者需要第二次 c-RFA 治疗,40%的患者因可见病灶需要再次内镜下切除。肿瘤完全缓解率为 100%,肠上皮化生完全缓解率为 95%。
在同一次治疗中,c-RFA 后立即进行内镜下切除术是可行的,但技术要求高,并发症发生率和再次内镜下切除率高。这种方法应保留在专家中心的选定病例中,内镜下切除联合 6-8 周后 RFA 仍然是标准的联合治疗方法。